ArticleJournal of oncology2022

NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer.

Chenzheng Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.